These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping. Zugazagoitia J; Ramos I; Trigo JM; Palka M; Gómez-Rueda A; Jantus-Lewintre E; Camps C; Isla D; Iranzo P; Ponce-Aix S; García-Campelo R; Provencio M; Franco F; Bernabé R; Juan-Vidal O; Felip E; de Castro J; Sanchez-Torres JM; Faul I; Lanman RB; Garrido P; Paz-Ares L Ann Oncol; 2019 Feb; 30(2):290-296. PubMed ID: 30535340 [TBL] [Abstract][Full Text] [Related]
32. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors. Bunda S; Zuccato JA; Voisin MR; Wang JZ; Nassiri F; Patil V; Mansouri S; Zadeh G Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925295 [TBL] [Abstract][Full Text] [Related]
33. Genetic profiling of cancer with circulating tumor DNA analysis. Lu L; Bi J; Bao L J Genet Genomics; 2018 Feb; 45(2):79-85. PubMed ID: 29502957 [TBL] [Abstract][Full Text] [Related]
34. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA. Junqueira-Neto S; Batista IA; Costa JL; Melo SA Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027 [TBL] [Abstract][Full Text] [Related]
35. Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications. Croessmann S; Park BH Clin Adv Hematol Oncol; 2021 Mar; 19(3):155-161. PubMed ID: 33739964 [TBL] [Abstract][Full Text] [Related]
36. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer. Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353 [TBL] [Abstract][Full Text] [Related]
37. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer. Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations. Ogasawara A; Hihara T; Shintani D; Yabuno A; Ikeda Y; Tai K; Fujiwara K; Watanabe K; Hasegawa K Cancer Res Treat; 2020 Oct; 52(4):1219-1228. PubMed ID: 32599986 [TBL] [Abstract][Full Text] [Related]
39. Liquid biopsy in breast cancer: A comprehensive review. Alimirzaie S; Bagherzadeh M; Akbari MR Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931 [TBL] [Abstract][Full Text] [Related]
40. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer. Morrison GJ; Goldkorn A Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]